PURPOSE: Community-acquired pneumonia (CAP) is the most common infection leading to hospitalization in the USA. The objective of this study was to evaluate management practices for inpatient CAP in relation to Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines to identify opportunities for antibiotic and health care resource stewardship. METHODS: This was a retrospective cohort study of adults hospitalized for CAP at a single institution from 15 April 2008 to 31 May 2009. RESULTS: Of the 209 patients with CAP who presented to Denver Health Medical Center during the study period and were hospitalized, 166 (79 %) and 43 (21 %) were admitted to a medical ward and the intensive care unit (ICU), respectively. Sixty-one (29 %) patients were candidates for outpatient therapy per IDSA/ATS guidance with a CURB-65 score of 0 or 1 and absence of hypoxemia. Sputum cultures were ordered for 110 specimens; however, an evaluable sample was obtained in only 49 (45 %) cases. Median time from antibiotic initiation to specimen collection was 11 [interquartile range (IQR) 6-19] h, and a potential pathogen was identified in only 18 (16 %) cultures. Blood cultures were routinely obtained for both non-ICU (81 %) and ICU (95 %) cases, but 15 of 36 (42 %) positive cultures were false-positive results. The most common antibiotic regimen was ceftriaxone + azithromycin (182, 87 % cases). Discordant with IDSA/ATS recommendations, oral step-down therapy consisted of a new antibiotic class in 120 (66 %), most commonly levofloxacin (101, 55 %). Treatment durations were typically longer than suggested with a median of 10 (IQR 8-12) days. CONCLUSIONS: In this cohort of patients hospitalized for CAP, management was frequently inconsistent with IDSA/ATS guideline recommendations, revealing potential targets to reduce unnecessary antibiotic and healthcare resource utilization.
PURPOSE: Community-acquired pneumonia (CAP) is the most common infection leading to hospitalization in the USA. The objective of this study was to evaluate management practices for inpatient CAP in relation to Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines to identify opportunities for antibiotic and health care resource stewardship. METHODS: This was a retrospective cohort study of adults hospitalized for CAP at a single institution from 15 April 2008 to 31 May 2009. RESULTS: Of the 209 patients with CAP who presented to Denver Health Medical Center during the study period and were hospitalized, 166 (79 %) and 43 (21 %) were admitted to a medical ward and the intensive care unit (ICU), respectively. Sixty-one (29 %) patients were candidates for outpatient therapy per IDSA/ATS guidance with a CURB-65 score of 0 or 1 and absence of hypoxemia. Sputum cultures were ordered for 110 specimens; however, an evaluable sample was obtained in only 49 (45 %) cases. Median time from antibiotic initiation to specimen collection was 11 [interquartile range (IQR) 6-19] h, and a potential pathogen was identified in only 18 (16 %) cultures. Blood cultures were routinely obtained for both non-ICU (81 %) and ICU (95 %) cases, but 15 of 36 (42 %) positive cultures were false-positive results. The most common antibiotic regimen was ceftriaxone + azithromycin (182, 87 % cases). Discordant with IDSA/ATS recommendations, oral step-down therapy consisted of a new antibiotic class in 120 (66 %), most commonly levofloxacin (101, 55 %). Treatment durations were typically longer than suggested with a median of 10 (IQR 8-12) days. CONCLUSIONS: In this cohort of patients hospitalized for CAP, management was frequently inconsistent with IDSA/ATS guideline recommendations, revealing potential targets to reduce unnecessary antibiotic and healthcare resource utilization.
Authors: W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane Journal: Thorax Date: 2003-05 Impact factor: 9.139
Authors: Elisa García-Vázquez; María Angeles Marcos; José Mensa; Andrés de Roux; Jordi Puig; Carmen Font; Gloria Francisco; Antonio Torres Journal: Arch Intern Med Date: 2004-09-13
Authors: Norihiro Yogo; Katherine Shihadeh; Heather Young; Susan L Calcaterra; Bryan C Knepper; William J Burman; Philip S Mehler; Timothy C Jenkins Journal: Infect Control Hosp Epidemiol Date: 2017-03-06 Impact factor: 3.254
Authors: Norihiro Yogo; Michelle K Haas; Bryan C Knepper; William J Burman; Philip S Mehler; Timothy C Jenkins Journal: Infect Control Hosp Epidemiol Date: 2015-04 Impact factor: 3.254
Authors: Sarah H Yi; Kelly M Hatfield; James Baggs; Lauri A Hicks; Arjun Srinivasan; Sujan Reddy; John A Jernigan Journal: Clin Infect Dis Date: 2018-04-17 Impact factor: 9.079
Authors: Barbara E Jones; Dave S Collingridge; Caroline G Vines; Herman Post; John Holmen; Todd L Allen; Peter Haug; Charlene R Weir; Nathan C Dean Journal: Appl Clin Inform Date: 2019-01-02 Impact factor: 2.342
Authors: Michelle K Haas; Kristen Dalton; Bryan C Knepper; Sarah A Stella; Lilia Cervantes; Connie S Price; William J Burman; Philip S Mehler; Timothy C Jenkins Journal: Open Forum Infect Dis Date: 2016-09-01 Impact factor: 3.835
Authors: Manuela Carugati; Stefano Aliberti; Luis Felipe Reyes; Ricardo Franco Sadud; Muhammad Irfan; Cristina Prat; Nilam J Soni; Paola Faverio; Andrea Gori; Francesco Blasi; Marcos I Restrepo Journal: ERJ Open Res Date: 2018-10-08
Authors: Valerie M Vaughn; Tejal N Gandhi; Vineet Chopra; Lindsay A Petty; Daniel L Giesler; Anurag N Malani; Steven J Bernstein; Lama M Hsaiky; Jason M Pogue; Lisa Dumkow; David Ratz; Elizabeth S McLaughlin; Scott A Flanders Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079